1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Once-daily fluticasone furoate and vilanterol for adolescents and adults with symptomatic asthma

      ,

      Annals of Allergy, Asthma & Immunology

      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Fluticasone furoate and vilanterol is a new inhaled corticosteroid (ICS) and long-acting β2-agonist (LABA) combination developed for once-daily administration via a dry powder inhaler.

          Related collections

          Author and article information

          Journal
          Annals of Allergy, Asthma & Immunology
          Annals of Allergy, Asthma & Immunology
          Elsevier BV
          10811206
          June 2016
          June 2016
          : 116
          : 6
          : 565-570
          Article
          10.1016/j.anai.2016.03.035
          27117053
          © 2016

          Comments

          Comment on this article